Ethicon linear cutter patent infringement suit against USSC dismissed by court.
This article was originally published in The Gray Sheet
Executive Summary
ETHICON ENDO-SURGERY PATENT INFRINGEMENT SUIT AGAINST U.S. SURGICAL DISMISSED Aug. 31 by Judge S. Arthur Spiegel, United States District Court in Cincinnati, Ohio. Ethicon claimed in its lawsuit that USSC's GIA and Endo GIA linear cutting/stapling instruments infringed Claims 6 and 24 of Ethicon's "Fox Reissue Patent," Number 34,519; the patent covers a lockout component that prevents the user from accidentally cutting tissue without having staples loaded in the cutter.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.